1
Home
Companies

Signal Genetics

Signal Genetics
Leadership team

Victor R. Ambros (Scientific Advisory Board Member)

Jeffery D. Molkentin (Scientific Advisory Board Member)

Eva van Rooij (Scientific Advisory Board Member)

Products/ Services
Health Care, Health Diagnostics, Innovation Management
Number of Employees
50 - 100
Headquarters
Carlsbad, California, United States
Established
2010
Company Registration
SEC CIK number: 0001590750
Traded as
NASDAQ:SGNL
Social Media
URL
www.signalgenetics.com/
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Signal Genetics, Inc. is a national commercial reference laboratory specializing in hematopathology and genetic cancer testing services.
History

Signal Genetics was founded in 2005 to provide personalized clinical laboratory services in the area of hematopathology and tumor genetics. The company is headquartered in Germantown, MD, and is a leader in cancer-focused diagnostics, developing the most comprehensive portfolio of focused hematology and genomics tests available in the industry.

Mission
We strive to develop and provide innovative, personalized laboratory diagnostic products integrating genetic, serologic and tissue-based assessment of malignant hematology & relevant tumor types to healthcare providers at community hospitals and specialty centers globally.
Vision
At Signal Genetics, we strive to be a global leader in molecular diagnostics, merging the advantages of scientific expertise and personalized patient service with the most comprehensive portfolio of focused hematology and genomics tests available.
Key Team

Stefanie Dimmeler (Scientific Advisory Board Member)

Arlene M. Morris (Independent Director)

Frank Slack (Scientific Advisory Board Member)

Tomas Kiselak (Independent Chairperson of Board)

Peter Evan Harwin (Independent Director)

Jennifer K. Moses (Independent Director)

Eric N. Olson (Co-Founder & Chairman of Scientific Advisory Board)

Marvin H. Caruthers (Co-Founder & Scientific Advisory Board Member)

Michael R. Bristow (Co-Founder & Member of the Scientific Advisory Board)

Jonathan Violin (Co-Founder, CEO, President & Director)

Recognition and Awards
Signal Genetics has been the recipient of multiple awards, including the 2015 Bio-IT World Innovative Life Science Company of the Year award, the 2015 Bio-IT World Best Practices in Technology Award, and the 2016 Wall Street Journal Technology Innovation Award. The company has also been named to 2014's Genome 50 list of top innovators, the 2016 Inc. 500 ranking of the nation's fastest-growing private companies, and received praise from the American Cancer Society in 2017 for its commitment to advancing cancer care.
References

https://in.investing.com/equities/signal-genetics

https://www.crunchbase.com/organization/signal-genetics

www.signalgenetics.com/

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Signal Genetics
Leadership team

Victor R. Ambros (Scientific Advisory Board Member)

Jeffery D. Molkentin (Scientific Advisory Board Member)

Eva van Rooij (Scientific Advisory Board Member)

Products/ Services
Health Care, Health Diagnostics, Innovation Management
Number of Employees
50 - 100
Headquarters
Carlsbad, California, United States
Established
2010
Company Registration
SEC CIK number: 0001590750
Traded as
NASDAQ:SGNL
Social Media
URL
www.signalgenetics.com/